SDG 3. GOOD HEALTH & WELL-BEING InterVenn Biosciences

InterVenn Biosciences Announces Clinical Validation of World’s First Glycoproteomic Diagnostic Test

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #AI–InterVenn Biosciences announces it has completed clinical and analytical validation of GLORI, a liquid-biopsy diagnostic test for female pelvic tumors

Read more on Business Wire Technology News

You may also like

Comments are closed.